Cargando…

N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma

BACKGROUND: N6-methyladenosine (m6A)-mediated ribonucleic acid (RNA) methylation is considered to be the most significant and abundant epigenetic modification in eukaryotic cells, and plays an essential role in the carcinogenesis and molecular pathogenesis of hepatocellular carcinoma (HCC). However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shen, Yan, Jingya, Zhang, Yize, Dong, Zihui, Xing, Jiyuan, He, Yuting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859781/ https://www.ncbi.nlm.nih.gov/pubmed/33553352 http://dx.doi.org/10.21037/atm-20-7396

Ejemplares similares

Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2021)

Overview of distinct N6-Methyladenosine profiles of messenger RNA in osteoarthritis
por: Yu, Yang, et al.
Publicado: (2023)

Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer
por: Yu, Zhun, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma
por: Li, Gao, et al.
Publicado: (2020)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

Predictive value of N6-methyladenosine (m6A)-related genes for prognosis and correlation with tumor microenvironment in gastric cancer
por: Yin, Tengfei, et al.
Publicado: (2022)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

Classification of Signature-Based Phenotypes of Aging-Related Genes to Identify Prognostic and Immune Characteristics in HCC
por: Zhao, Junjie, et al.
Publicado: (2023)

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
por: Wang, Dan, et al.
Publicado: (2023)

Comprehensive Analysis of N6-Methyladenosine (m(6)A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas
por: Liu, Duanrui, et al.
Publicado: (2022)

Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas
por: Cai, Zhiqiang, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Gene signature of m(6)A RNA regulators in diagnosis, prognosis, treatment, and immune microenvironment for cervical cancer
por: Wang, Shizhi, et al.
Publicado: (2022)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

Long Non-coding RNA Small Nucleolar RNA Host Gene 14, a Promising Biomarker and Therapeutic Target in Malignancy
por: Shen, Shen, et al.
Publicado: (2021)

Expression of N(6)-methyladenosine (m(6)A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)
por: Xie, Zucheng, et al.
Publicado: (2021)

Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases
por: Wang, Yuting, et al.
Publicado: (2023)

Dynamic Patterns of N6-Methyladenosine Profiles of Messenger RNA Correlated with the Cardiomyocyte Regenerability during the Early Heart Development in Mice
por: Yang, Yuhui, et al.
Publicado: (2021)

N6-Methyladenosine (m(6)A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients
por: Chen, Yuqing, et al.
Publicado: (2023)

Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer
por: Lin, Gaoteng, et al.
Publicado: (2021)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

The roles and therapeutic implications of messenger RNA internal N (7)‐methylguanosine and N (6)‐methyladenosine modifications in chemoresistance
por: Zhao, Zhicong, et al.
Publicado: (2023)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

Comprehensive Analysis of N(6)-Methyladenosine (m(6)A) Methylation in Neuromyelitis Optica Spectrum Disorders
por: Yang, Hong, et al.
Publicado: (2021)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

A Ten-N(6)-Methyladenosine (m(6)A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma
por: Huang, Wei, et al.
Publicado: (2021)

Genetic Regulation of N6-Methyladenosine-RNA in Mammalian Gametogenesis and Embryonic Development
por: Chang, Yuguang, et al.
Publicado: (2022)

The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma
por: Li, Fei, et al.
Publicado: (2021)

An N(6)-methyladenosine-associated lncRNA signature for predicting clinical outcome and therapeutic responses in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4i00f4lrolslnj6tm4adqt55o